← Browse by Condition
Medical Condition

insomnia

Total Trials
19
Recruiting Now
19
Trial Phases
EARLY_Phase 1, Phase 1, Phase 2, Phase 2

ClinicalMetric tracks all active clinical trials for insomnia sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — insomnia Clinical Trials

How many clinical trials are currently recruiting for insomnia?
ClinicalMetric currently tracks 19 actively recruiting clinical trials for insomnia, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 19. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for insomnia?
insomnia research spans Phase 1 (2 trials), Phase 2 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a insomnia clinical trial?
Eligibility criteria for insomnia trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
2
Phase 2
2
Top Sponsors
Beijing Tiantan Hospital 3 trials
Woolcock Institute of Medical Research 1 trial
Brigham and Women's Hospital 1 trial
Seoul National University Hospital 1 trial
Nanjing First Hospital, Nanjing Medical University 1 trial

Recruiting Clinical Trials

NCT06376760
Recruiting
Changes in Intravenous Anesthetic Drug Dosage in Insomnia Patients Undergoing Digestive Endoscopy
Enrollment
3,360 pts
Location
China
Sponsor
Beijing Tiantan Hospital
View Trial →
NCT06802913 EARLY_Phase 1
Recruiting
A Novel Inhaled Formulation of Melatonin to Treat Adults With Insomnia: Efficacy Study
Enrollment
10 pts
Location
Australia
Sponsor
Woolcock Institute of Medical ...
View Trial →
NCT06972303 Phase 1, Phase 2
Recruiting
Mindfulness Meditation for Insomnia
Enrollment
30 pts
Location
United States
Sponsor
Brigham and Women's Hospital
View Trial →
NCT06222255
Recruiting
The Safety and Efficacy of Transanal Irrigation in Patients With Sleep Disturbance From Low Anterior Resection Syndrome After Rectal Cancer Surgery (TraLARS)
Enrollment
52 pts
Location
South Korea
Sponsor
Seoul National University Hosp...
View Trial →
NCT06773143
Recruiting
Effect of Subanesthetic Dose of Esketamine on Sleep Quality
Enrollment
184 pts
Location
China
Sponsor
Nanjing First Hospital, Nanjin...
View Trial →
NCT06434571 Phase 2
Recruiting
Comparing Telehealth-Delivered CBT-I to Web-Based CBT-I to Enhance Sleep, Reduce Fatigue, and Promote Neuroprotection
Enrollment
90 pts
Location
United States
Sponsor
University of Kansas Medical C...
View Trial →
NCT06498128
Recruiting
Registry to Collect Information on Pregnancy, Neonatal, and Infant Outcomes in Pregnant Women Exposed to QUVIVIQ®
Enrollment
785 pts
Location
United States, Canad...
Sponsor
Idorsia Pharmaceuticals Ltd.
View Trial →
NCT04896775
Recruiting
NiteCAPP: Web-based Interventions for Insomnia in Rural Dementia Caregivers
Enrollment
100 pts
Location
United States
Sponsor
University of South Florida
View Trial →
NCT05390918
Recruiting
Targeting Adolescent Insomnia to Lessen Overall Risk of Suicidal Behavior
Enrollment
235 pts
Location
United States
Sponsor
Jeff Bridge
View Trial →
NCT05456607
Recruiting
Digital CBT for Insomnia and Depression
Enrollment
1,200 pts
Location
United States
Sponsor
University of Rochester
View Trial →
NCT07191119
Recruiting
Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia
Enrollment
40 pts
Location
United States
Sponsor
St. Jude Children's Research H...
View Trial →
NCT07270406
Recruiting
Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain
Enrollment
200 pts
Location
United States
Sponsor
Washington University School o...
View Trial →
NCT05674357
Recruiting
Training in Evidence-based Treatments in Psycho-Oncology
Enrollment
115 pts
Location
United States
Sponsor
Massachusetts General Hospital
View Trial →
NCT06897007
Recruiting
Changes in Ciprofol Dosage in Insomnia Patients Undergoing Digestive Endoscopy
Enrollment
840 pts
Location
China
Sponsor
Beijing Tiantan Hospital
View Trial →
NCT04962087
Recruiting
Health enSuite Insomnia: an App-based Treatment for Adult Chronic Insomnia
Enrollment
415 pts
Location
Canada
Sponsor
IWK Health Centre
View Trial →
NCT07028177
Recruiting
Changes in Etomidate Dosage in Insomnia Patients Undergoing Digestive Endoscopy
Enrollment
840 pts
Location
China
Sponsor
Beijing Tiantan Hospital
View Trial →
NCT06736548
Recruiting
Sleep Treatment Education Program for Cancer Survivors: STEP-Together
Enrollment
100 pts
Location
United States
Sponsor
Dana-Farber Cancer Institute
View Trial →
NCT06375447
Recruiting
Intelligent Diagnosis and Treatment Model for Insomnia Disorder
Enrollment
16,000 pts
Location
China
Sponsor
Xuanwu Hospital, Beijing
View Trial →
NCT07417813
Recruiting
A Multicenter Observational Study of Lemborexant on Insomnia Patients With Psychiatric Disorders
Enrollment
121 pts
Location
China
Sponsor
Shanghai Mental Health Center
View Trial →

Related Conditions

digestive endoscopy (3) insomnia chronic (2) sleep initiation and maintenance disorders (1) mindfulness (1) telemedicine (1) low anterior resection syndrome (1) rectal cancer (1) sleep disorder (1) breast cancer surgery (1) esketamine (1) multiple sclerosis (1) dementia (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology